AI Takes On Drug Discovery
In this Genetic Engineering & Biotechnology News article, reporter Mike May takes a fresh look at how using AI for drug discovery reveals new targets and tactics for treating diseases. Molecular Devices’ Angeline Lim weighs in with ways AI-enabled image analysis software uncovers more insights while healing the pains of a traditional, manual approach. She’s joined in the conversation by X-Chem, Inc.'s Noor Shaker, Charles River Laboratories' Grant Wishart, and Insilico Medicine's Alex Zhavoronkov.